Clinical Trials Market — Highlights Clinical trial is research study which involve people (healthy volunteers or patients) to test the safety and efficacy of a new treatment or medicine. In healthcare industry clinical trials are performed for medicine, medical devices which includes hearing aid and surgical procedure. The key factors driving the clinical trial industry includes rising prevalence of diseases, high R&D expenditure of the pharmaceutical industry, and growth of new treatments such as personalized medicine is supporting to grow the market. However, factors such as lack of skilled workforce clinical research, lower healthcare reimbursement in the developing countries and stringent regulations for patient enrollment, hinder the market growth. Get Premium Free Sample Report at https://www.marketresearchfuture.com/sample_request/7787 Segmental Analysis: The global clinical trials market has been segmented based on phase, study design, indication, end users, and region. Based on the phase, the market has been segmented into phase I, phase II, phase III, and phase IV. Among these, the phase III trial segment has been assessed to lead the market as the largest segment, owing to its high value in the healthcare sector, as well as its comparatively superior effectiveness. Phase I trial segment has been expected to grow at the fastest growth rate during the forecast period, owing to the increase in its applications in investigative new drug (IND) sector, technological advancements, and the rising government initiatives to improve the healthcare sector in emerging economies. Based on the study design, the global clinical trials market has been segmented into expanded access interventional, and observational. Based on indication, the global clinical trials market has been segmented into autoimmune/inflammation, cardiovascular, central nervous system (CNS) condition, diabetes, obesity, oncology, pain management, and others. Based on the end-user, the clinical trials market is segmented into dental hospitals & clinics, dental institutes, and dental academic and research institutes. Based on the region, the global clinical trials market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). Key Players: Charles River Laboratories, Paraxel International Corporation, Quintiles IMS, ICON plc, SGS SA, Eli Lilly and Company, Novo Nordisk A/S, Clinipace, Laboratory Corporation of America, Pfizer and Others are some of the major players for global clinical trials market. Get More Information At https://www.marketresearchfuture.com/reports/clinical-trials-market-7787 Regional Analysis: On the regional basis, the global clinical trial market in the Americas is segmented into two major regions, i.e., North America and Latin America. The North American region is likely to hold the major share in the global clinical trial market owing to the presence of well-established healthcare sector, growing prevalence of high diseases and also increasing funding from government. Additionally, the Asia-Pacific region is anticipated to be the fastest growing region due to increasing geriatric population with either one or more disease and favorable environment such as low operating cost, skilled technician and increasing healthcare facilities provides favorable scenario for the market growth.